<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://openbell.ai/</loc>
    <lastmod>2026-11-06T07:43:49.527Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://openbell.ai/support</loc>
    <lastmod>2026-11-06T07:43:49.527Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://openbell.ai/privacy</loc>
    <lastmod>2026-11-06T07:43:49.527Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/terms</loc>
    <lastmod>2026-11-06T07:43:49.527Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/feed.json</loc>
    <lastmod>2026-11-06T07:43:49.527Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://openbell.ai/news/RELAIS:1793948560000</loc>
    <lastmod>2026-11-06T07:02:40.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RELAIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Relais Group Reports Q3 2026 Earnings Beat</image:title>
      <image:caption>Relais Group reported a third-quarter 2026 earnings beat, exceeding expectations. Its Technical Wholesale segment underperformed compared with the company’s other business areas. The report provided no specific financial figures or stock-price impact.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SUY1V:1793948555000</loc>
    <lastmod>2026-11-06T07:02:35.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SUY1V/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Suominen Corporation&#39;s Interim Report for January 1–September 30, 2026</image:title>
      <image:caption>Suominen Corporation reported higher sales and comparable EBITDA in the third quarter of 2026, supported by increased production volumes, lower fixed costs, and early benefits from internal programs. Operating cash flow was negative due to inventory accumulation and operational disruptions at U.S. facilities. The company maintained its full-year guidance for comparable EBITDA to exceed the €12.6 million reported in 2025.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PAMPALO:1793948501000</loc>
    <lastmod>2026-11-06T07:01:41.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PAMPALO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Endomines Finland Oyj Reports Q3 2026 Financial Results</image:title>
      <image:caption>Endomines Finland Oyj reported that revenue for the first nine months of 2026 rose 42% to €47 million, while EBITDA increased 45% to €18.5 million. The company reaffirmed its full-year 2026 production growth guidance of 10%–20%. Management cited ongoing exploration and development of the Southern Gold Line as key parts of its long-term expansion strategy.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TOKMAN:1793948496000</loc>
    <lastmod>2026-11-06T07:01:36.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TOKMAN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Tokmanni Group Reports Q3 2026 Financial Results</image:title>
      <image:caption>Tokmanni Group reported a 2.9% increase in revenue in Q3 2026, while rising costs weighed on comparable EBIT. The company also recorded €36.3 million in exceptional impairment and inventory charges during the first nine months of the year. Dollarstore improved, but overall performance led Tokmanni to lower its previously announced 2026 guidance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HEPS:1793944882000</loc>
    <lastmod>2026-11-06T06:01:22.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HEPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Hepsiburada Announces Third Quarter 2026 Financial Results</image:title>
      <image:caption>Hepsiburada reported unaudited third-quarter 2026 revenue of TRY 24,264.9 million, down 6.1% from a year earlier. Revenue declines in first-party sales and other revenue were partly offset by growth in marketplace and delivery services. EBITDA shifted to a loss of TRY 134.1 million from positive TRY 225.4 million, while free cash flow fell 73.5% to TRY 888.9 million.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/JNJ:1793934098000</loc>
    <lastmod>2026-11-06T03:01:38.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/JNJ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>FDA Grants Accelerated Approval for RYBREVANT FASPRO in Head and Neck Squamous Cell Carcinoma</image:title>
      <image:caption>The FDA granted Johnson &amp; Johnson accelerated approval for RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) to treat adults with recurrent or metastatic head and neck squamous cell carcinoma that progressed during or after platinum-based chemotherapy and anti-PD-(L)1 therapy. The approval excludes HPV-associated oropharyngeal cancer and expands the drug’s use beyond its existing oncology indications. The article reports no financial figures or stock-price impact.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HIMX:1793926912000</loc>
    <lastmod>2026-11-06T01:01:52.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HIMX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Himax Technologies, Inc. Reports Third Quarter 2026 Financial Results and Provides Fourth Quarter 2026 Guidance</image:title>
      <image:caption>Himax Technologies reported third-quarter 2026 revenue of $246.8 million, up 8.5% sequentially and 23.9% year over year. GAAP earnings were $0.11 per diluted ADS, above the $0.09 analyst consensus, while gross margin was 34.2%, in line with guidance. For the fourth quarter, the company expects revenue to fall 22%–26% sequentially and earnings of $0.045–$0.065 per ADS, citing abrupt short-term order adjustments by some automotive customers despite its stated long-term market position.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SNDK:1793925170153</loc>
    <lastmod>2026-11-06T00:32:50.153Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SNDK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Social Media Discussion: $SNDK</image:title>
      <image:caption>Sentiment is mixed: bullish on ARK’s SpaceX share purchase, but bearish amid a sharp Dow drop and tech correction.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/WEN:1793925166707</loc>
    <lastmod>2026-11-06T00:32:46.707Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/WEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Social Media Discussion: $WEN</image:title>
      <image:caption>Neutral — Wendy’s shares were reportedly the only stock up that day, despite rejecting Nelson Peltz’s $1.4 billion takeover offer.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/QQQ:1793925164753</loc>
    <lastmod>2026-11-06T00:32:44.753Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/QQQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Social Media Discussion: $QQQ</image:title>
      <image:caption>Sentiment: Bullish. Key theme: QQQ bounced off its weekly trend line, while a trader reported a 2,000% gain on QQQ puts.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HALO:1793919793000</loc>
    <lastmod>2026-11-05T23:03:13.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HALO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Halozyme Therapeutics Reports Q3 2026 Financial Results and Raises Full-Year Guidance</image:title>
      <image:caption>Halozyme Therapeutics reported third-quarter 2026 revenue of $493 million, up 39.2% year over year, including royalty revenue of $341 million, up 44%. Non-GAAP earnings were $2.39 per diluted share, exceeding analyst consensus. The company raised its 2026 guidance to revenue of $1.86 billion–$1.93 billion and non-GAAP diluted EPS of $8.75–$9.05.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BL:1793919785000</loc>
    <lastmod>2026-11-05T23:03:05.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BlackLine, Inc. Reports Third Quarter 2026 Financial Results and Announces Stock Buyback Increase</image:title>
      <image:caption>BlackLine reported third-quarter 2026 GAAP revenue of $193.4 million, up 8.5% year over year, with a GAAP operating margin of 8.6% and a non-GAAP operating margin of 25.9%. GAAP net income attributable to the company was $10.6 million, or $0.18 per diluted share. BlackLine also increased its existing stock buyback authorization by $100 million and cited strong profitability, cash flow, and continued customer adoption of its platform.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TMDX:1793919769000</loc>
    <lastmod>2026-11-05T23:02:49.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TMDX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>TransMedics Group, Inc. Reports Third Quarter 2026 Financial Results</image:title>
      <image:caption>TransMedics Group reported third-quarter 2026 revenue of $203.0 million, up 41% year over year, driven by higher Liver and Heart volumes through its National OCS Program and contributions from logistics services and its PAD Aviation acquisition. Operating income rose to $28.1 million from $23.3 million a year earlier. The company also received full FDA IDE approvals in October for Part B of the OCS ENHANCE Heart trial and the DENOVO Lung trial, and management cited strong momentum entering 2027.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IONQ:1793919768000</loc>
    <lastmod>2026-11-05T23:02:48.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IONQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>IonQ, Inc. Reports Q3 2026 Financial Results and Raises Full-Year Revenue Guidance</image:title>
      <image:caption>IonQ reported Q3 2026 revenue of $173.8 million, above the FactSet consensus estimate of $141.5 million. Its adjusted loss was $0.29 per share, narrower than the expected $0.35 loss. The company raised its full-year 2026 revenue guidance to $505 million–$515 million, compared with the prior FactSet estimate of $456.2 million.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GRND:1793919768000</loc>
    <lastmod>2026-11-05T23:02:48.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GRND/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Grindr Inc. Reports Third Quarter 2026 Financial Results and Updates Guidance</image:title>
      <image:caption>Grindr Inc. reported a 22% increase in revenue in the third quarter of 2026. The company raised its full-year 2026 financial guidance and provided an initial outlook for fiscal 2027. The results and updates were released on November 5, 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CSH.UN:1793919767000</loc>
    <lastmod>2026-11-05T23:02:47.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CSH.UN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Chartwell Announces Strong Q3 2026 Results</image:title>
      <image:caption>Chartwell Retirement Residences reported its third-quarter 2026 results on November 5, 2026, marking its 13th consecutive quarter of double-digit growth in Funds from Operations per unit. The company cited continued operational momentum in Canada’s senior living sector; the article did not provide specific revenue, profit, or stock-price figures.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/LASR:1793919763000</loc>
    <lastmod>2026-11-05T23:02:43.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LASR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>nLIGHT, Inc. Reports Q3 2026 Financial Results and Q4 Guidance</image:title>
      <image:caption>nLIGHT reported third-quarter 2026 revenue of $73.8 million, above the FactSet consensus estimate of $68.2 million. Adjusted EPS was $0.16, compared with the $0.05 estimate. The company forecast fourth-quarter revenue of $84 million to $90 million and disclosed the results in an SEC 8-K filing on November 5, 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HLIO:1793919762000</loc>
    <lastmod>2026-11-05T23:02:42.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HLIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Helios Technologies, Inc. Reports Q3 2026 Financial Results and Provides Q4 Outlook</image:title>
      <image:caption>Helios Technologies reported Q3 2026 revenue of $229.7 million, above the FactSet consensus estimate of $219.9 million. Adjusted EPS was $0.80, exceeding the $0.76 estimate. For Q4 2026, the company expects revenue of $205.0 million to $212.0 million and adjusted EPS of $0.60 to $0.67.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MAT:1793919757000</loc>
    <lastmod>2026-11-05T23:02:37.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Mattel, Inc. Reports Q3 2026 Financial Results and Updates Annual Guidance</image:title>
      <image:caption>Mattel reported Q3 2026 revenue of $1.81 billion, up 4% in reported sales, adjusted EPS of $1.30, and adjusted operating income of $502 million. Margin expansion was significantly supported by $88 million in tariff refunds. The company updated its 2026 adjusted EPS outlook to $1.05–$1.20, below the FactSet consensus of $1.29; the guidance excludes the third-quarter tariff refunds.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NNI:1793919756000</loc>
    <lastmod>2026-11-05T23:02:36.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NNI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nelnet, Inc. Reports Q3 2026 Financial Results</image:title>
      <image:caption>Nelnet reported third-quarter 2026 adjusted earnings of $1.89 per share, above the FactSet consensus estimate of $1.83. Revenue was $436.6 million, also exceeding the $427.4 million estimate. The results reflect its diversified operations, including student loan servicing and education technology services.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/FG:1793919756000</loc>
    <lastmod>2026-11-05T23:02:36.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>F&amp;G Annuities &amp; Life Reports Third Quarter 2026 Results</image:title>
      <image:caption>F&amp;G Annuities &amp; Life reported third-quarter 2026 adjusted net earnings of $96 million, or $0.74 per share, down from $165 million, or $1.22 per share, a year earlier. GAAP net earnings were $736 million, or $5.48 per diluted share, significantly boosted by favorable market-related liability adjustments. Gross sales totaled $3.0 billion, including $2.3 billion in core sales and nearly $700 million in opportunistic sales. Common shareholders’ equity excluding AOCI reached $6.7 billion at September 30, 2026, increasing with market-related adjustments and the annual actuarial reserve review.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CARG:1793919755000</loc>
    <lastmod>2026-11-05T23:02:35.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CARG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CarGurus Announces Third Quarter 2026 Financial Results</image:title>
      <image:caption>CarGurus reported third-quarter 2026 revenue of $258.4 million, up 11.5% to 12% year over year, and GAAP net income from continuing operations of $52.8 million. The company launched StockVantage, a new inventory pillar for its AI-enabled dealer workflow solutions. For the fourth quarter, it forecast revenue of $258.5 million to $263.5 million and adjusted EPS of $0.73 to $0.79, while emphasizing disciplined execution and free cash flow.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NOG:1793919754000</loc>
    <lastmod>2026-11-05T23:02:34.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Northern Oil and Gas, Inc. Reports Q3 2026 Financial Results</image:title>
      <image:caption>Northern Oil and Gas reported third-quarter 2026 adjusted EPS of $1.32, above the FactSet consensus estimate of $1.09. Revenue was $697.7 million, exceeding the $617.7 million estimate. The company operates as an independent energy firm with non-operated working and mineral interests.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/WK:1793919754000</loc>
    <lastmod>2026-11-05T23:02:34.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/WK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Workiva Inc. Reports Q3 2026 Financial Results and Provides Guidance</image:title>
      <image:caption>Workiva reported Q3 2026 revenue of $263.0 million, above the $261.4 million FactSet estimate, while adjusted EPS of $0.72 missed the $0.80 estimate. Subscription revenue rose 17% year over year to $246 million, and the non-GAAP operating margin expanded 560 basis points to 18.3%. For Q4, Workiva expects revenue of $275 million to $278 million and adjusted EPS of $0.78 to $0.80; it reaffirmed full-year 2026 revenue guidance of $1.041 billion to $1.044 billion.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SMR:1793919751000</loc>
    <lastmod>2026-11-05T23:02:31.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SMR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>NuScale Power Corporation Reports Third Quarter 2026 Financial Results</image:title>
      <image:caption>NuScale Power Corporation reported third-quarter 2026 revenue of $281,000 as work on the RoPower project concluded. Its net loss narrowed to $45.7 million, largely reflecting the impact of a prior-year PMA charge. At September 30, the company had $513.4 million in cash, $420.0 million in short-term investments, and $930.7 million in total investments; management said it expects to have sufficient funding for operations beyond the next 12 months.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BDGI:1793919750000</loc>
    <lastmod>2026-11-05T23:02:30.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BDGI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Badger Infrastructure Solutions Ltd. Reports Record Third Quarter 2026 Results</image:title>
      <image:caption>Badger Infrastructure Solutions reported record third-quarter 2026 revenue of $286.5 million, up 21% from $237.3 million a year earlier. Adjusted EBITDA increased 25% to $83.4 million, with a 29.1% margin; revenue per truck per month rose 8% to $51,895, and its hydrovac fleet expanded 11% to 1,882 units. The board approved a fourth-quarter 2026 cash dividend of CAD$0.195 per common share, payable on or after January 15, 2027, to shareholders of record on December 31, 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VERA:1793919749000</loc>
    <lastmod>2026-11-05T23:02:29.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VERA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Vera Therapeutics Reports Third Quarter 2026 Financial Results and Business Update</image:title>
      <image:caption>Vera Therapeutics reported $10.3 million in net product revenue for the third quarter ended September 30, 2026. Its U.S. launch of TRUTAKNA, which received FDA accelerated approval on July 7, generated approximately 700 Patient Start Forms to date. The final ORIGIN 3 analysis showed a 76% lower risk of composite kidney disease progression versus placebo over two years, and Vera submitted an sBLA seeking full FDA approval for TRUTAKNA in adults with primary IgAN.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/WSC:1793919749000</loc>
    <lastmod>2026-11-05T23:02:29.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/WSC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>WillScot Holdings Corporation Reports Third Quarter 2026 Results</image:title>
      <image:caption>WillScot reported third-quarter 2026 revenue of $601 million and net income of $52 million, with Adjusted EBITDA of $234 million and a 38.8% margin, up 160 basis points sequentially. Leasing revenue rose 4%, delivery and installation revenue increased 22.7%, and modular unit activations grew 12% year over year. After results exceeded its outlook, the company raised its 2026 revenue and Net CAPEX guidance and provided early expectations for Adjusted EBITDA growth and deleveraging in 2027.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/DIOD:1793919748000</loc>
    <lastmod>2026-11-05T23:02:28.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DIOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Diodes Incorporated Reports Q3 2026 Financial Results and Provides Q4 Outlook</image:title>
      <image:caption>Diodes Incorporated reported Q3 2026 revenue of $532.59 million, above the FactSet estimate of $512.9 million, and adjusted EPS of $1.18, exceeding the $1.08 estimate. The company attributed growth to automotive market-share gains, stronger industrial demand, and momentum in the AI ecosystem. For Q4 2026, it forecast revenue of $533.5 million to $566.5 million and adjusted EPS of $1.25 to $1.45.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/FIGS:1793919748000</loc>
    <lastmod>2026-11-05T23:02:28.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FIGS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>FIGS, Inc. Reports Q3 2026 Revenue of $190.7 Million</image:title>
      <image:caption>FIGS, Inc. reported third-quarter 2026 revenue of $190.7 million, exceeding the FactSet analyst estimate of $182.8 million. The healthcare apparel brand continues to focus on its digital-first, direct-to-consumer sales model.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CXW:1793919747000</loc>
    <lastmod>2026-11-05T23:02:27.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CXW/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CoreCivic Reports Third Quarter 2026 Financial Results and Facility Sale</image:title>
      <image:caption>CoreCivic reported third-quarter 2026 revenue of $744.09 million and diluted EPS of $14.49, with net income boosted by a $1.77 billion gain on selling four detention facilities to the Department of Homeland Security for about $2.21 billion in gross proceeds. The company will continue managing the facilities under existing ICE contracts, while residential segment revenue rose 15.2%. CoreCivic said it used sale proceeds to repay debt and launch a new $500 million share repurchase program.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IRTC:1793919747000</loc>
    <lastmod>2026-11-05T23:02:27.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IRTC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>iRhythm Holdings, Inc. Reports Third Quarter 2026 Financial Results</image:title>
      <image:caption>iRhythm Holdings reported third-quarter 2026 revenue of $221.6 million, up 14.9% year over year, with gross margin improving 310 basis points to 74.2%. Adjusted EBITDA was $51.2 million and adjusted net income was $27.8 million, while the company recorded a GAAP net loss of $29.9 million. For full-year 2026, iRhythm expects revenue of $890 million to $895 million, including about $16 million from its VitalConnect acquisition, which closed October 5, 2026. Management cited sustained customer demand and efficiency-driven operating leverage.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/KRMN:1793919746000</loc>
    <lastmod>2026-11-05T23:02:26.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KRMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Karman Space &amp; Defense Reports Third Quarter Fiscal Year 2026 Financial Results</image:title>
      <image:caption>Karman Space &amp; Defense reported record financial results for the third quarter of fiscal year 2026. The article provides no revenue, profit, growth figures, or further details about its operations in the space and defense sectors.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GRDN:1793919745000</loc>
    <lastmod>2026-11-05T23:02:25.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GRDN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Guardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year Guidance</image:title>
      <image:caption>Guardian Pharmacy Services reported third-quarter 2026 revenue of $371.1 million, with the figure reflecting pricing decreases associated with the Inflation Reduction Act. The company served approximately 218,000 residents, up 7% year over year, and raised its full-year guidance. The article did not provide profit figures or details of the revised guidance.</image:caption>
    </image:image>
  </url>
</urlset>